18:16 IST
BSE
Annual General Meeting
Bal Pharma Annual General Meeting
Bal Pharma Ltd held its 39th Annual General Meeting on September 24, 2026, where shareholders transacted all business items as per the notice.
Bal Pharma Ltd
- Share price
- ₹97.50
- Market cap
- ₹155.2 Cr
- Revenue (annual)
- ₹311.7 Cr
- Net profit (annual)
- ₹6.28 Cr
- P/E (TTM)
- 21.5×Sector 47.4×
- Promoter holding
- 50.86%+0.00% QoQ
- FII holding
- 0.15%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Capital Structure Change 3Annual General Meeting 3Other Announcement 2Management Change 2Price Movement Clarification 1Merger & Restructuring 1Financial Results 1Dividend 1Annual Report 1
Time
3 announcements with these filters
17:20 IST
BSE
Annual General Meeting
Bal Pharma Annual General Meeting
Bal Pharma Limited will hold its 39th Annual General Meeting on September 24, 2026. The record date for the final dividend is September 17, 2026.
16:55 IST
BSE
Annual General Meeting
Bal Pharma Annual General Meeting
Bal Pharma Ltd released the Scrutinizer's Report on postal ballot voting results regarding the proposed preferential issue of 1,000,000 warrants to the promoter.